Upm Pharmaceuticals, Inc. competitors

Joe Ciaffoni was appointed President and Chief Executive Officer of Collegium Pharmaceutical in July 2018. Joe Ciaffoni joined Collegium Pharmaceutical in May 2017 as Executive Vice President and Chief Operating Officer. Prior to joining Collegium, he served as President, U.S. Branded Pharmaceuticals of Endo International plc. Before that, Joe Ciaffoni held various positions of increasing responsibility at Biogen, including Senior Vice President, Global Specialty Medicines Group, Senior Vice President, U.S. Commercial and Vice President, U.S. Neurology Field Operations and Marketing. Prior to joining Biogen, he was Executive Vice President and Chief Operating Officer of Shionogi Inc. and President of Shionogi Pharmaceuticals. Joe Ciaffoni also previously served as Vice President, Sales for Schering-Plough (now Merck) and held several commercial leadership roles at Sanofi-Synthelabo (now Sanofi) and Novartis. Joe Ciaffoni received a B.A. in Communications and an M.B.A. from Rutgers.

Cameron Reid is a Board Member at CHEMINOR DRUGS LIMITED and Chief Executive Officer at Interpharm Holdings Inc. He has worked as President at DR. REDDY'S LABORATORIES and Board Member at Interpharm Holdings Inc. Cameron works or has worked as Executive Vice President at Roussel NV. He studied at UCalgary and INSEAD.

David Seltzer is a Chairman/Pres/CEO/Treasurer at HI TECH PHARMACAL CO INC, Board Member at NovelStem International Corp, and Owner at Leading Pharma. He has experience at Bergen Brunswig Corp and AMERISOURCEBERGEN CORP and has worked as Exec VP:Admin/Treasurer/Secy at HI TECH PHARMACAL CO INC, Treasurer/Secretary at HI TECH PHARMACAL CO INC, and VP:Admin/COO/Treasurer/Secy at HI TECH PHARMACAL CO INC. David attended Queens University of Charlotte.

An entrepreneurial executive specializing in growth strategies. Managing, motivating and coaching people toward a common business goal is a core strength. Experience includes Board of Directors, IPO, M&A, Sales, Business Development, Marketing and Operations. Expertise in start-ups to Fortune 6 environments.Applied growth strategies within the following market segments:In Vitro Diagnostics, Instrument Development, Single-Use bioreactors, Gene Expression Analysis, GMP services, Filtration, Cell Culture, Microscopy, Protein Crystallography, Liquid Chromatography, DNA/RNA chemistry, Peptide chemistry, Biologics, Biosimilars and Drug Development.

Accomplished scientific leader with more than 30 years of pharmaceutical experience. From discovery through research & development, analytical (method development, validation, etc.) and quality control drug discovery and management experience in top-tier multinational pharmaceutical organizations. A global, strategic thinker, with demonstrated ability to deliver pre-clinical and clinical candidates, within stringent timelines. Acknowledged as a creative leader focused on advancing projects with experience in multiple therapeutic areas. Expert in optimizing the drug discovery process through optimal resource allocation, process improvements and using scientific acumen to resolve complex project related issues. Recognized ability to lead, recruit, energize, mentor, reward and retain talent. Specialties: Executive Management / Pharmaceuticals / Drug Discovery & Development / Pre-Clinical & Clinical Development / Product Development / Start-Up Experience/ Analytical chemistry / Preformulation / Marine natural products (microbial) / Marine biology /Chemistry / Pharmaceuticals